Phase IIb Study Evaluating Immunogenic Chemotherapy Combined with Ipilimumab and Nivolumab in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Molecular Evaluation in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).
- Status
- COMPLETED
- Phase
- PHASE4
Olaparib In Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combination Study of SV-BR-1-GM With Retifanlimab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Patterns of Prescribing and Monitoring of Palbociclib
- Status
- COMPLETED
- Phase
- N/A
Palbociclib in Real World Practice
- Status
- COMPLETED
- Phase
- N/A
Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
- Status
- RECRUITING
- Phase
- N/A
Her2-BATS and Pembrolizumab in Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone: A Whole Body MRI Study
- Status
- UNKNOWN
- Phase
- NA
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Understanding Value in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Halaven Patient Registry (Metastatic Breast Cancer, MBC)
- Status
- UNKNOWN
- Phase
- N/A
An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2